News

Zions Bancorporation Celebrates 13 Awards for Banking Excellence

Zions Bancorporation Celebrates 13 Awards for Banking Excellence

Celebrating 13 Coalition Greenwich Best Bank Awards

Zions Bancorporation, N.A. (NASDAQ: ZION), has made headlines recently by earning an impressive 13 Best Bank Awards from Coalition Greenwich. This recognition highlights Zions' commitment to serving middle market and small business clients effectively. Notably, the bank secured the third highest number of awards in the middle market banking segment, showcasing its strong position in this critical area.

Since the inception of these awards in 2009, Zions Bancorporation has consistently stood out, being one of only four U.S. banks to average 15 or more middle market and small business Coalition Greenwich Best Bank Awards annually. The bank's achievements have culminated in a remarkable total of 246 awards to date.

Understanding the Coalition Greenwich Awards

The Coalition Greenwich Best Bank Awards are rooted in comprehensive market research, involving around 25,000 interviews with businesses across the country. This extensive evaluation assesses more than 500 banks to determine which institutions are providing measurable distinctive quality in service. Zions Bancorporation has excelled in various surveyed areas, including customer satisfaction, trustworthiness, and product capabilities.

With commendable insights into customers' perceptions, Coalition Greenwich focuses on the importance of long-term relationships and the quality of advice offered by banks. This approach ensures clients receive the best support to facilitate their business growth.

Customer-Centric Values at Zions Bancorporation

In a statement, Harris H. Simmons, the chairman and CEO of Zions Bancorporation, emphasized the bank's commitment to providing exceptional service. “We continually strive to create value for our customers. Being recognized as one of the best banks in the industry based on research by Coalition Greenwich is a great honor,” Simmons remarked. He pointed out that this recognition underscores the high value customers place on their relationships with the bank's team, who work diligently to deliver excellence every day.

Categories of Excellence Awarded

Zions Bancorporation has received accolades in various categories which highlight its strengths:

Middle Market ($10-$500 million in annual sales)

  • Best Bank – Overall Satisfaction
  • Best Bank – Trust
  • Best Bank – Values Long-Term Relationships
  • Best Bank – Customer Service
  • Best Bank – Advisory Capabilities of Relationship Manager
  • Best Bank – Satisfaction with Relationship Manager
  • Best Bank – Satisfaction in Cash Management
  • Best Bank – Product Capabilities in Cash Management
  • Best Bank – Likelihood to Recommend (West)
  • Best Bank – Overall Satisfaction (West)
  • Best Bank – Satisfaction with Relationship Manager (West)
  • Best Bank – Satisfaction in Cash Management (West)

Small Business ($1-$10 million in annual sales)

  • Best Bank – Customer Service

Zions Bancorporation: A Leader in Financial Services

Zions Bancorporation is recognized as one of the premier financial services companies in the United States, boasting approximately $89 billion in total assets and generating $3.1 billion in annual net revenue in the most recent financial year. Operating under a variety of distinct brands in 11 western states, Zions has effectively built a customer-focused approach while adhering to local management strategies.

The bank excels in small and middle-market banking, public finance advisory services, and Small Business Administration lending, helping many businesses succeed. Additionally, Zions Bancorporation is prominently listed in major indices such as the S&P MidCap 400 and NASDAQ Financial 100, further solidifying its strong market presence.

Frequently Asked Questions

What awards did Zions Bancorporation receive?

Zions Bancorporation received 13 Best Bank Awards, including confirmations in overall satisfaction and customer service.

How does Zions Bancorporation measure customer satisfaction?

They utilize comprehensive research, conducting around 25,000 interviews to evaluate customer perceptions and satisfaction across various metrics.

What segments did Zions perform best in?

The bank was particularly recognized in the middle market and small business segments for its service quality and customer relationships.

Who is the CEO of Zions Bancorporation?

Harris H. Simmons is the chairman and CEO of Zions Bancorporation.

Where can I find more information about Zions Bancorporation?

More details about Zions Bancorporation can be found through their official channels and investor information resources.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 273

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 308

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading
MWC26 Doha: Bridging Standards for MENA's Future

Updated Category News Views 501

MWC26 Doha Launches with a Connectivity Mission Forget corporate boardrooms; the real action this week is unfolding in Doha's bustling exhibition halls. Kicked off with the fanfare you'd expect from such a key event, MWC26 Doha has drawn a crowd that's got both tech geeks and policy wonks nodding with interest. This ain’t your average trade show: it’s the melting pot...

Continue Reading
Webull Faces Class Action Suit: Key Deadlines Loom

Updated Category News Views 236

The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....

Continue Reading
Intelligent Communication Forum Eyes Global Ecosystem Shift

Updated Category News Views 595

China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...

Continue Reading
Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 344

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 337

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading
Stavian Group Eyes AI-Driven Southeast Asia Growth

Updated Category News Views 18

AI and Infrastructure: A New Chapter for Southeast Asia What does Southeast Asia's future look like with AI steering the ship? Well, there's a fresh breeze of change blowing, and right at the heart of it stands Stavian Group. At the recently held inaugural Fortune SEA500 Summit in Ho Chi Minh City, this conglomerate threw its hat into the ring, painting a vision of growth...

Continue Reading
Innovent's SINTBILO® Hits Primary Endpoint in Study

Updated Category News Views 78

Innovent's Latest Breakthrough with SINTBILO® One moment you're sipping coffee, the next you're staring at a clinical milestone. Innovent Biologics has shouted from the rooftops that their drug, SINTBILO® (tafolecimab injection), has wrapped up its Phase 3 CREDIT-5 study, snagging the primary endpoint with both hands. This isn't just any drug; it's marked as the first...

Continue Reading
GlycoNex Eyes Japanese Market with Denosumab Biosimilar

Updated Category News Views 45

A Strategic Step into the Japanese Market Alright folks, there's a new kid aiming to shake things up in the biotech neighborhood, and it's GlycoNex with its denosumab biosimilar, SPD8. These guys just tossed their hat in the ring with a regulatory submission to Japan's Pharmaceuticals and Medical Devices Agency (PMDA). If the cosmic forces align, they might snag an...

Continue Reading

Top 5 Most Recently Viewed Articles

Investigation Initiated for Voyager Therapeutics Investors

Updated Category News Views 115

Investigation Overview for Voyager Therapeutics Investors Pomerantz LLP is currently exploring possible claims on behalf of investors in Voyager Therapeutics, Inc. (NASDAQ: VYGR). This exploration arises from concerns surrounding the company’s recent announcements and operational strategies. Details of the Investigation The inquiry focuses on whether Voyager and some of...

Continue Reading
Subway's Creative Middle Seat Reward for Travelers

Updated Category News Views 132

Subway Announces Exciting Promotion for Air Travelers On January 27, a significant change is happening for travelers, especially for those who dread sitting in the middle seat of a plane. With a popular airline ending its open seating policy, millions are gearing up for assigned seating. This means that many passengers might find themselves in the middle seat, which is...

Continue Reading
Expanse Studios Unveils Innovative Games at Major Summit

Updated Category News Views 86

Expanse Studios Shines at Industry Summit Expanse Studios, a cutting-edge gaming developer and a subsidiary of Golden Matrix Group Inc. (NASDAQ: GMGI), has made a significant impression at the recent SBC Summit Lisbon. This event attracted around 25,000 attendees, featuring a mix of gaming innovators and industry experts, all eager to explore what's next in the gaming...

Continue Reading
Unlocking Digital Preservation Skills Through New Academy

Updated Category News Views 150

Introducing the Preservica Academy for Digital Preservation Preservica Inc. has unveiled its exciting new initiative, Preservica Academy, dedicated to enhancing the skills of professionals and beginners in the realm of digital preservation. This innovative program focuses on Active Digital Preservation™, aiming to ensure the long-term accessibility and integrity of...

Continue Reading
Seritage Growth Properties Investors Alert: Class Action Lawsuit Update

Updated Category News Views 107

Notification of Class Action Lawsuit for Seritage Growth Properties Levi & Korsinsky, LLP is reaching out to inform investors of Seritage Growth Properties (NYSE: SRG) regarding an ongoing class action securities lawsuit. This case marks an important development for those affected by alleged securities fraud. Overview of the Class Action Lawsuit This lawsuit is centered...

Continue Reading